Pandora's Box: mitochondrial defects in ischaemic heart disease and stroke

Area of Science:

• Cardiovascular Science
• Mitochondrial Biology
• Genetics

Background:

• Ischaemic heart disease and stroke are leading global vascular events with complex pathogenesis.
• Mitochondrial involvement, including reactive oxygen species and pericyte impact, is increasingly recognized.
• While nuclear gene roles are established, mitochondrial DNA's (mtDNA) contribution to these disorders is less understood.

Purpose of the Study:

• To explore the molecular events and mitochondrial DNA (mtDNA) alterations in ischaemic heart disease and stroke.
• To elucidate the role of mitochondria in the pathophysiology of these vascular events.
• To highlight the growing evidence for mitochondria and mtDNA involvement in vascular disease.

Main Methods:

• Review of recent genetic and epigenetic findings.
• Analysis of molecular mechanisms involving mitochondria.
• Exploration of mitochondrial DNA (mtDNA) alterations.

Main Results:

• Mitochondrial reactive oxygen species contribute to pathogenesis via oxidized LDL and apoptosis.
• Mitochondria impact pericytes, directly influencing ischaemic heart disease and stroke development.
• Emerging evidence links mitochondria and mtDNA alterations to vascular events, suggesting a larger role than previously thought.

Conclusions:

• Mitochondria and their DNA (mtDNA) are critically involved in the pathogenesis of ischaemic heart disease and stroke.
• Further research into mtDNA alterations and mitochondrial function is crucial for understanding and potentially treating these vascular events.
• The complex interplay between nuclear and mitochondrial factors warrants continued investigation.